Overcoming Drug Resistance and Treating Advanced Prostate Cancer

By  

Current Drug Targets, Vol. 13, Iss. 10, 2012-09 ,pp. : 1308-1323

Bentham Science Publishers

Access to resources Recommend Favorite

Hormonal therapy in advanced prostate cancer examined

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer

By McKeage Mark J  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 1, 2008-01 ,pp. : 23-29

Informa Healthcare

Access to resources Recommend Favorite

Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer

By Tsintavis Athanassios   Lambou Theocharis   Vacalicos John   Koutsilieris Michael   Karamanolakis Dimitrios   Bogdanos John   Milathianakis Constantine   Mitsiades Constantine   Dimopoulos Theodoros  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 2, 2002-02 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Antiandrogen Withdrawal Syndrome Associated with Prostate Cancer Therapies: Incidence and Clinical Significance

By Paul R.   Breul J.  

Drug Safety, Vol. 23, Iss. 5, 2000-11 ,pp. : 381-390

Adis International

Access to resources Recommend Favorite